+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

Fibrodysplasia Ossificans Progressiva (FOP) Pipeline Analysis 2019 (H1) - Product Thumbnail Image

Fibrodysplasia Ossificans Progressiva (FOP) Pipeline Analysis 2019 (H1)

  • Report
  • May 2019
  • 80 Pages
  • Global
From
Europe Mid-Size Pharmaceutical Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Drug Development Type, Formulation, and Therapy Class - Product Thumbnail Image

Europe Mid-Size Pharmaceutical Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Drug Development Type, Formulation, and Therapy Class

  • Report
  • September 2022
  • 73 Pages
  • Europe
From
Asia Pacific Mid-Size Pharmaceutical Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Drug Development Type, Formulation, and Therapy Class - Product Thumbnail Image

Asia Pacific Mid-Size Pharmaceutical Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Drug Development Type, Formulation, and Therapy Class

  • Report
  • September 2022
  • 146 Pages
  • Asia Pacific
From
North America Mid-Size Pharmaceutical Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Drug Development Type, Formulation, and Therapy Class - Product Thumbnail Image

North America Mid-Size Pharmaceutical Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Drug Development Type, Formulation, and Therapy Class

  • Report
  • September 2022
  • 135 Pages
  • North America
From
Mid-Size Pharmaceutical Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type, Drug Development Type, Formulation, and Therapy Class - Product Thumbnail Image

Mid-Size Pharmaceutical Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type, Drug Development Type, Formulation, and Therapy Class

  • Report
  • June 2022
  • 203 Pages
  • Global
From
Retinopathy Of Prematurity - Pipeline Review, H2 2020 - Product Thumbnail Image

Retinopathy Of Prematurity - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 68 Pages
  • Global
From
Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 60 Pages
  • Global
From
Familial Amyloid Neuropathies Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Familial Amyloid Neuropathies Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 59 Pages
  • Global
From
Keloids Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Keloids Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 43 Pages
  • Global
From
Bullous Pemphigoid Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Bullous Pemphigoid Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 55 Pages
  • Global
From
Bullous Pemphigoid - Pipeline Review, H1 2020 - Product Thumbnail Image

Bullous Pemphigoid - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 139 Pages
  • Global
From
Gene Therapy Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028 - Product Thumbnail Image

Gene Therapy Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028

  • Report
  • July 2022
  • 100 Pages
  • Global
From
Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes in Q2 2022 - Thematic Research - Product Thumbnail Image

Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes in Q2 2022 - Thematic Research

  • Report
  • July 2022
  • 25 Pages
  • Global
From
Eosinophilic Esophagitis - Pipeline Review, H2 2020 - Product Thumbnail Image

Eosinophilic Esophagitis - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 151 Pages
  • Global
From
Fasinumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Fasinumab Emerging Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
Clinical Trials Sector Scorecard, Q2 2022 Update - Thematic Research - Product Thumbnail Image

Clinical Trials Sector Scorecard, Q2 2022 Update - Thematic Research

  • Report
  • June 2022
  • 16 Pages
  • Global
From
Extractables and Leachables Testing Services Market, 2018-2028 - Product Thumbnail Image

Extractables and Leachables Testing Services Market, 2018-2028

  • Report
  • September 2018
  • 200 Pages
  • Global
From
Stroke - Pipeline Review, H2 2020 - Product Thumbnail Image

Stroke - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 773 Pages
  • Global
From
Clinical Trials Sector Scorecard - Thematic Research - Product Thumbnail Image

Clinical Trials Sector Scorecard - Thematic Research

  • Report
  • October 2021
  • 24 Pages
  • Global
From
Eosinophilic Esophagitis - Opportunity Assessment and Forecast to 2030 - Product Thumbnail Image

Eosinophilic Esophagitis - Opportunity Assessment and Forecast to 2030

  • Report
  • December 2021
  • 83 Pages
  • Global
From
Loading Indicator